Abstract
Outer membrane vesicles (OMVs) are promising vaccine components because they combine antigen and adjuvant in a single formulation. Detoxified Salmonella enterica strains that express penta-acylated lipid A retain OMV immunogenicity but with reduced reactogenicity. We have previously shown that a recombinant form of the enterotoxigenic Escherichia coli (ETEC) 17 kilodalton protein (Skp) protects mice in a pulmonary challenge model, when fused to the glutathione-S-transferase (GST) epitope and combined with cholera toxin. Here we compared directly the efficacy of expressing Skp in detoxified Salmonella OMVs to GST-Skp for their ability to protect mice against ETEC challenge. We observed that the display of Skp on OMVs, in the absence of exogenous adjuvant, protects the mice as well as the recombinant GST-Skp with adjuvant, showing that we can achieve protection when antigen and adjuvant are administered as a single formulation. Collectively, these data demonstrate the utility of using OMVs for the expression and display of antigens for use in vaccine development and validate previously published work demonstrating that immunization with Skp is efficacious in protecting mice against ETEC challenge.
References
Feb 11, 1998·Clinical Microbiology Reviews·J P Nataro, J B Kaper
Nov 21, 1998·Molecular Microbiology·L Hashemzadeh-BonehiJ K Broome-Smith
Oct 28, 2003·The Journal of Biological Chemistry·Nicole C Kesty, Meta J Kuehn
Nov 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robert C AlanizBrad T Cookson
May 31, 2008·Journal of Molecular Biology·Jae-Young KimMatthew P DeLisa
Nov 13, 2008·Infection and Immunity·Stefan SchildAndrew Camilli
Sep 15, 2009·Vaccine·Juliane Schroeder, Toni Aebischer
Nov 4, 2009·Microbes and Infection·James M FleckensteinHans Steinsland
Mar 4, 2010·Microbiology and Molecular Biology Reviews : MMBR·Terri N Ellis, Meta J Kuehn
Dec 1, 2010·Infection and Immunity·Maneesha MuralinathRoy Curtiss
Sep 21, 2011·Infection and Immunity·Qingke KongRoy Curtiss
Jun 16, 2012·Nature Reviews. Immunology·David M Underhill, Helen S Goodridge
Jun 20, 2012·Microbial Cell Factories·Wouter S P JongJoen Luirink
May 13, 2014·Immunotherapy·Susanna EspositoJeffrey Stoddard
Jul 20, 2014·Applied and Environmental Microbiology·Maria H Daleke-SchermerhornJoen Luirink
Nov 26, 2014·Microbial Cell Factories·Wouter S P JongJoen Luirink
Mar 18, 2015·Vaccine·Kirsten KuipersMarien I de Jonge
Aug 6, 2015·PLoS Neglected Tropical Diseases·Amit KumarPhilip R Hardwidge
Dec 27, 2016·Frontiers in Cellular and Infection Microbiology·Michael P HaysPhilip R Hardwidge
May 20, 2017·Biotechnology Advances·Matthias J H GerritzenMichiel Stork
Jul 19, 2017·Infection and Immunity·Kirsten KuipersMarien I de Jonge
Citations
Oct 16, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xinpeng JiangDi Liu
Sep 11, 2019·Cancers·Yingxuan ZhangQiong Liu
Jun 2, 2020·Frontiers in Microbiology·H Bart van den Berg van SaparoeaWouter S P Jong
Mar 27, 2020·Frontiers in Cellular and Infection Microbiology·Christian Rueter, Martina Bielaszewska
Jan 1, 2021·Drug Discovery Today·Yan Shan LooThiagarajan Madheswaran
Oct 23, 2020·Science Advances·Guillaume MasSebastian Hiller
Apr 5, 2021·Vaccine·M J KlouwensJ W Hovius
Jan 27, 2019·Microbiology Spectrum·Jessica D CecilAnne Marie Krachler
Aug 11, 2021·MBio·Zhuang ZhuAnders Miki Bojesen